Peptide Research Database

Mitochondrial & Metabolic

For Research Use Only. Not for Human or Veterinary Use.

Overview

Peptides that target mitochondrial function and metabolism — mitochondrial-derived peptides (MOTS-c, Humanin), the cardiolipin-targeting tetrapeptide SS-31, the lipolytic hGH fragment AOD-9604 and a comparison page.

CompoundClassMechanismPrimary research targets
MOTS-cMitochondrial-derived peptideAMPK / SIRT1, exercise mimeticInsulin sensitivity, exercise, aging
SS-31 (Elamipretide)Cardiolipin-targeting tetrapeptideCardiolipin binding, ETC supportMitochondrial function, ischemia
HumaninMitochondrial-derived peptideBax/Bid inhibition, cytoprotectionNeuroprotection, longevity
AOD-9604Modified hGH fragmentAdipocyte β-adrenergic lipolysisLipolysis, cartilage repair

How Mitochondrial Peptides Work

This category targets mitochondrial and metabolic biology from different angles. Mitochondrial-derived peptides (MOTS-c, Humanin) are encoded within mitochondrial DNA and act as stress-responsive regulators — MOTS-c on AMPK and metabolism, Humanin on anti-apoptotic cytoprotection. SS-31 (elamipretide) binds cardiolipin to stabilise the inner mitochondrial membrane and electron transport. AOD-9604 is a growth-hormone C-terminal fragment studied for fat metabolism without the GH / IGF-1 axis.

1. Mitochondrial biogenesis & dynamics

MOTS-c via AMPK/SIRT1; SS-31 stabilises cardiolipin and electron transport; Humanin maintains membrane potential.

2. Energy metabolism

MOTS-c promotes glucose uptake and fatty-acid oxidation; AOD-9604 stimulates lipolysis; SS-31 improves ATP efficiency.

3. Cellular stress & cytoprotection

Humanin is anti-apoptotic (Bax/Bid); SS-31 scavenges superoxide and blocks the permeability-transition pore; MOTS-c activates the UPRmt.

4. Metabolic-hormone signalling

MOTS-c acts as an exercise mimetic (FGF21, METRNL); AOD-9604 targets adipocyte β-adrenergic receptors.

Key Properties at a Glance

CompoundCAS numberMW (Da)LengthMechanismHalf-life
MOTS-c1626405-30-4≈ 2174.616 aaAMPK / SIRT1, exercise mimetic~ 2–4 h
SS-31 (Elamipretide)736992-21-5639.814 aaCardiolipin binding, ETC support~ 2–4 h
Humanin330936-65-3≈ 2687.224 aaBax/Bid inhibition, cytoprotection~ 1–3 h
AOD-9604221231-10-3≈ 1815.116 aaAdipocyte β-adrenergic lipolysis~ 2–4 h

Research Evidence Summary

Representative reported findings from the literature (qualitative). See each compound page for detail.

CompoundKey reported findingReference
MOTS-cImproved insulin sensitivity and glucose toleranceLee C et al., 2015
MOTS-cEnhanced exercise capacity in aged animalsReynolds JC et al., 2020
MOTS-cAMPK-mediated metabolic (exercise-mimetic) effectsMOTS-c literature
SS-31Improved mitochondrial respiration; reduced oxidative stressSiegel MP et al.
SS-31Reduced ischemia–reperfusion injurySzeto HH; Birk AV et al.
SS-31Clinical-stage in primary mitochondrial myopathyStealth BioTherapeutics
HumaninProtection against amyloid-β toxicityHashimoto Y et al., 2001
HumaninImproved insulin sensitivityMuzumdar RH et al.
HumaninCytoprotection via Bax/Bid inhibitionHumanin literature
AOD-9604Stimulated lipolysis without GH-receptor activationNg FM et al.
AOD-9604Reduced body fat without glucose or IGF-1 effectspreclinical literature
AOD-9604Enhanced chondrocyte proteoglycan synthesispreclinical literature

Research Dosing Overview

Typical research dose ranges from the literature (for research reference only, not human dosing guidance):

CompoundResearch doseRouteFrequencyDuration
MOTS-c5–15 mgSC / IP1–2×/wk4–12 wk
SS-31 (Elamipretide)0.5–2 mgSC / IVDaily2–8 wk
Humanin2–8 mgSC / IV1–2×/day4–12 wk
AOD-9604300–1000 µgSCDaily4–12 wk

Formulation & Reconstitution

FactorRecommendation
SolventBacteriostatic water (0.9% benzyl alcohol)
Reconstitution1–2 mL per vial (peptide-dependent)
Storage (lyophilized)−20°C, desiccated, protected from light
Storage (reconstituted)2–8°C for up to 7–14 days
pH stability range5.0–7.0
Oxidation-sensitive residuesProtect Met / Cys peptides from air and light; add antioxidant where relevant

Selected References

  • Lee C, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis. Cell Metabolism, 2015.
  • Reynolds JC, et al. MOTS-c is an exercise-induced regulator of physical decline. Nature Communications, 2020.
  • Hashimoto Y, et al. Humanin, a neuroprotective rescue factor. Proceedings of the National Academy of Sciences, 2001.
  • Szeto HH. Cardiolipin-targeting peptides (SS-31 / elamipretide) research literature.

Need research-grade peptides?

HPLC-verified, COA per batch. Tell us the quantity you need.

Request a Quote